Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TheraTest is a specialized diagnostic company focused on the development and manufacturing of high-quality immunoassay kits for the detection of autoimmune diseases. The company is best known for its EL-ANA and EL-ENA product lines, which provide standardized and quantitative results for systemic rheumatic diseases. TheraTest's proprietary technology simplifies complex diagnostic workflows, offering clinicians reliable tools for the management of conditions like systemic lupus erythematosus and rheumatoid arthritis. Following its acquisition by Eurofins Scientific in 2021, TheraTest continues to operate as a key provider of autoimmune diagnostic solutions within the Eurofins clinical diagnostics network. The company maintains a strong reputation for precision and reliability in the rheumatology diagnostic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TheraTest.